Publication | Closed Access

Exosome-based tumor antigens–adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA

Cell-based Drug DeliveryTumor ImmunologyMedicineImmunologyTherapeutic VaccineExtracellular MicrovesiclesCancer VaccinesImmunotherapeuticsTumor TargetingImmunostimulatory Cpg DnaImmunotherapyCell EngineeringCell BiologyExosomesTumor Cell-derived Exosomes